AngioDynamics Stock Analysis

AngioDynamics Stock Analysis Notes

About 97.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 1.19. Some equities with similar Price to Book (P/B) outperform the market in the long run. AngioDynamics has Price/Earnings To Growth (PEG) ratio of 1.87. The entity recorded a loss per share of 0.96. The firm had not issued any dividends in recent years. AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and vascular access and for use in oncology and surgical settings in the United States and internationally. The company was founded in 1988 and is headquartered in Latham, New York. Angiodynamics operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 760 people. For more info on AngioDynamics please contact Joseph DeVivo at 518 795 1400 or go to https://www.angiodynamics.com.

AngioDynamics Investment Alerts

AngioDynamics Upcoming and Recent Events

AngioDynamics Largest EPS Surprises

View All Earnings EstimatesView All Earnings Estimates

AngioDynamics SEC Filings

AngioDynamics Thematic Classifications

AngioDynamics Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 378.24 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate AngioDynamics's market, we take the total number of its shares issued and multiply it by AngioDynamics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

AngioDynamics Profitablity

The company has Profit Margin (PM) of (0.11) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.07) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.07.

Management Efficiency

AngioDynamics has return on total asset (ROA) of (0.0283) % which means that it has lost $0.0283 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.09) %, meaning that it created substantial loss on money invested by shareholders. AngioDynamics' management efficiency ratios could be used to measure how well AngioDynamics manages its routine affairs as well as how well it operates its assets and liabilities. As of 2nd of June 2023, Return on Investment is likely to drop to -7.39. In addition to that, Return on Average Assets is likely to drop to -0.05. AngioDynamics Net Current Assets as percentage of Total Assets are very stable at the moment as compared to the past year. AngioDynamics reported last year Net Current Assets as percentage of Total Assets of 14.36. As of 2nd of June 2023, Tangible Assets Book Value per Share is likely to grow to 5.24, while Revenue to Assets are likely to drop 0.46.

Technical Drivers

AngioDynamics Price Movement Analysis

AngioDynamics Insider Trading Activities

AngioDynamics Technical and Predictive Indicators

AngioDynamics Forecast Models

AngioDynamics' time-series forecasting models are one of many AngioDynamics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary AngioDynamics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how AngioDynamics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling AngioDynamics shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as AngioDynamics. By using and applying AngioDynamics Stock analysis, traders can create a robust methodology for identifying AngioDynamics entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. AngioDynamics analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. AngioDynamics analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

AngioDynamics stock analysis indicators help investors evaluate how AngioDynamics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading AngioDynamics shares will generate the highest return on investment. By understating and applying AngioDynamics stock analysis, traders can identify AngioDynamics position entry and exit signals to maximize returns.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AngioDynamics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate. To learn how to invest in AngioDynamics Stock, please use our How to Invest in AngioDynamics guide. Note that the AngioDynamics information on this page should be used as a complementary analysis to other AngioDynamics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.

When running AngioDynamics' price analysis, check to measure AngioDynamics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AngioDynamics is operating at the current time. Most of AngioDynamics' value examination focuses on studying past and present price action to predict the probability of AngioDynamics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AngioDynamics' price. Additionally, you may evaluate how the addition of AngioDynamics to your portfolios can decrease your overall portfolio volatility.

Is AngioDynamics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AngioDynamics. If investors know AngioDynamics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AngioDynamics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of AngioDynamics is measured differently than its book value, which is the value of AngioDynamics that is recorded on the company's balance sheet. Investors also form their own opinion of AngioDynamics' value that differs from its market value or its book value, called intrinsic value, which is AngioDynamics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AngioDynamics' market value can be influenced by many factors that don't directly affect AngioDynamics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between AngioDynamics' value and its price as these two are different measures arrived at by different means. Investors typically determine if AngioDynamics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AngioDynamics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.